Rabkin v. Lion Biotechnologies, Inc., et al
Lion Biotechnologies Securities Litigation Settlement
Case No: 3:17-cv-02086-SI

Important Documents

(To view/download a document, click its name.) Get Adobe Reader

Settlement Class Member Documents

Notice of (I) Pendency of Class Action and Proposed Settlement; (II) Motion for an Award of Attorneys' Fees and Reimbursement of Litigation Expenses; and (III) Settlement Fairness Hearing
Proof of Claim and Release Form
Electronic Filing Instructions
Electronic Filing Template

Court Documents

Judgment Approving Class Action Settlement, dated April 17, 2019
Order Approving Plan of Allocation, dated April 17, 2019
Order Awarding Attorneys' Fees and Expenses, dated April 17, 2019
Supplemental Declaration of Jack Ewashko regarding (A) Mailing of Notice and Claim Form; (B) Report on Requests for Exclusion; and (C) Report on Claims Received to date, dated March 29, 2019
[Proposed] Judgment Approving Class Action Settlement dated March 29, 2019

[Proposed] Order Approving Plan of Allocation dated March 29, 2019

[Proposed] Order Awarding Attorneys' Fees and Expenses dated March 29, 2019
Reply Memorandum of Points and Authorities in further support of (I) Lead Plaintiff's Motion for Final Approval of Proposed Settlement and Plan of Allocation and (II) Lead Counsel's Motion for an award of Attorneys' Fees and Reimbursement of Litigation Expenses dated March 29, 2019
Lead Plaintiff's Notice of Motion and Motion for Final Approval of Proposed Settlement and Plan of Allocation and Memorandum of Points and Authorities in Support Thereof dated February 21, 2019
Lead Counsel's Notice of Motion and Motion for an Award of Attorney's Fees and Reimbursement of Litigation Expenses and Memorandum of Points and Authorities in Support Thereof dated February 21, 2019

Declaration of Jennifer L. Joost in support of (I) Lead Plaintiff's Motion for Final Approval of Proposed Settlement and Plan of Allocation; and (II) Lead Counsel's Motion for an Award of Attorney's Fees and Reimbursement of Litigation Expenses dated February 21, 2019

Order Preliminary Approving Settlement and Providing for Notice dated November 30, 2018
Stipulation of Settlement and Release dated September 28, 2018
Amended Complaint for Violation of the Federal Securities Laws dated September 8, 2017

FOR MORE INFORMATION

Visit this website often to get the most up-to-date information.

Mail

Lion Biotechnologies Securities Litigation Settlement
c/o JND Legal Administration
P.O. Box 91227
Seattle, WA 98111